7 episodi
T2D: Don’t Sugar Coat It Novo Nordisk
-
- Scienze
What are the main drivers of type 2 diabetes (T2D) and why does the diabetes epidemic continue to grow despite a wealth of information? Join series host Dr. John Anderson, past president of ADA, who practices internal medicine at the Frist Clinic, as he interviews fellow experts on the main drivers of T2D and how clinicians can optimize patient outcomes in this changing disease area.
Bonus episode with a focus on the indispensable role of pharmacists in T2D care hosted by Todd Eury, founder and CEO of the Pharmacy Podcast Network.
This podcast is sponsored by Novo Nordisk and is intended for clinicians.
-
The Indispensable Role of Pharmacists in T2D Care
Join episode host, Todd Eury, founder and CEO of the Pharmacy Podcast Network, as he discusses the indispensable role of pharmacists in T2D care with Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP and Rohit Moghe, PharmD, MSPH, CDCES.
-
Should We Be Thinking Differently About Type 2 Diabetes?
Join experts in T2D: Dr John Anderson (primary care provider), Ms Lucia Novak (Nurse Practitioner), and Dr Joshua Stolker (cardiologist) as they talk about ways to think differently about type 2 diabetes and consider factors in addition to A1C. This podcast is sponsored by Novo Nordisk and is intended for clinicians.
-
The Increased Risk of Cardiovascular Disease in Patients With T2D
Dr John Anderson, Dr Pam Taub, and Dr Mark Greathouse review the relationship between type 2 diabetes (T2D) and cardiovascular disease (CVD), including how T2D exacerbates CVD and the risk from CVD, and what the national medical associations recommend for patients with T2D and CVD. This podcast is sponsored by Novo Nordisk and is intended for clinicians.
-
Understanding Insufficient GLP-1 Activity in T2D
Join experts in T2D: Dr John Anderson, Dr Javier Morales, and Dr Richard Pratley as they review the impact of insufficient GLP-1 activity in patients with T2D. This podcast is sponsored by Novo Nordisk and is intended for clinicians.
-
The Role of Endogenous GLP-1
Join multidisciplinary experts in T2D: Dr John Anderson, Dr Vivian Fonseca, and Dr Jim Gavin as they discuss the fascinating history of GLP-1 discovery and the role of endogenous GLP-1 in the pathophysiology of T2D. This podcast is sponsored by Novo Nordisk and is intended for Healthcare Practitioners.
-
Beta-Cell Dysfunction: A Driver of T2D?
Join primary care experts in T2D: Dr. John Anderson, Dr. Stephen Brunton and Dr. James LaSalle as we discuss the beta-cell function and its critical role in T2D pathogenesis.